{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:21:07Z","timestamp":1773220867082,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":80,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.vaccine.2022.01.049","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T15:42:30Z","timestamp":1644075750000},"page":"1439-1447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of the effect of maternally derived antibody on response to MMR vaccine in Thai infants"],"prefix":"10.1016","volume":"40","author":[{"given":"Siyuan","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Logan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiratchaya","family":"Puenpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasamon","family":"Wanlapakorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sompong","family":"Vongpunsawad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Poovorawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Willett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret J.","family":"Hosie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"44","key":"10.1016\/j.vaccine.2022.01.049_b0005","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.15585\/mmwr.mm6544a6","article-title":"Progress toward regional measles elimination - worldwide, 2000\u20132015","volume":"65","author":"Patel","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"31","key":"10.1016\/j.vaccine.2022.01.049_b0010","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1016\/S0264-410X(03)00449-3","article-title":"Modelling measles re-emergence as a result of waning of immunity in vaccinated populations","volume":"21","author":"Mossong","year":"2003","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2022.01.049_b0015","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1023\/B:EJEP.0000040453.13914.48","article-title":"Re-emergence of measles among young adults in Marseilles, France","volume":"19","author":"Zandotti","year":"2003","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.01.049_b0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.7883\/yoken.66.6","article-title":"Reemergence of measles in South Korea: implications for immunization and surveillance programs","volume":"66","author":"Park","year":"2013","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.01.049_b0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.meegid.2016.12.013","article-title":"Measles re-emergence in Northern Italy: pathways of measles virus genotype D8, 2013\u20132014","volume":"48","author":"Amendola","year":"2017","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2022.01.049_b0030","unstructured":"WHO Regional Office for South-East Asia. Expanded programme on Immunization (EPI) factsheet 2020: Thailand; 2020."},{"key":"10.1016\/j.vaccine.2022.01.049_b0035","doi-asserted-by":"crossref","unstructured":"Wanlapakorn N, Wasitthankasem R, Vichaiwattana P, Auphimai C, Yoocharoen P, Vongpunsawad S, et al. Antibodies against measles and rubella virus among different age groups in Thailand: a population-based serological survey. PLoS One 2019;14:e0225606. doi: 10.1371\/journal.pone.0225606.","DOI":"10.1371\/journal.pone.0225606"},{"key":"10.1016\/j.vaccine.2022.01.049_b0040","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1016\/j.vaccine.2020.04.013","article-title":"Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9 months and 2.5 years: a longitudinal study","volume":"38","author":"Wanlapakorn","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.01.049_b0045","unstructured":"Annual Epidemiological Surveillance Report 2019. Department of Disease Control, Ministry of Public Health, Thailand; 2019."},{"issue":"2","key":"10.1016\/j.vaccine.2022.01.049_b0050","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1128\/jcm.22.2.296-298.1985","article-title":"Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status","volume":"22","author":"Neumann","year":"1985","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2022.01.049_b0055","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.03161-20","article-title":"Evaluation of diagnostic accuracy of eight commercial assays for the detection of measles virus-specific IgM antibodies","volume":"59","author":"Hiebert","year":"2021","journal-title":"J Clin Microbiol"},{"issue":"1-2","key":"10.1016\/j.vaccine.2022.01.049_b0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0166-0934(98)00178-5","article-title":"A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody","volume":"78","author":"Lee","year":"1999","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2022.01.049_b0065","doi-asserted-by":"crossref","unstructured":"Lee MS, Nokes DJ, Hsu HM, Lu CF. Protective titres of measles neutralising antibody. J Med Virol 2000;62:511\u20137. doi: 10.1002\/1096-9071(200012)62:4<511::aid-jmv17>3.0.co;2-z.","DOI":"10.1002\/1096-9071(200012)62:4<511::AID-JMV17>3.0.CO;2-Z"},{"issue":"1","key":"10.1016\/j.vaccine.2022.01.049_b0070","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/cid\/ciz778","article-title":"Quantity and quality of antibodies after acellular versus whole-cell pertussis vaccines in infants born to mothers who received tetanus, diphtheria, and acellular pertussis vaccine during pregnancy: a randomized trial","volume":"71","author":"Wanlapakorn","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.01.049_b0075","unstructured":"NIBSC. WHO 3rd International Standard For Anti-Measles (97\/648) 2008. Available from: https:\/\/www.nibsc.org\/documents\/ifu\/97-648.pdf (accessed July 30, 2021)."},{"key":"10.1016\/j.vaccine.2022.01.049_b0080","unstructured":"World Health Organisation. WHO immunological basis for immunization series: module 7: measles: update 2020. Immunol. basis Immun. Ser. 2020: 18."},{"issue":"1","key":"10.1016\/j.vaccine.2022.01.049_b0085","first-page":"379","article-title":"Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system","volume":"7","author":"DuBridge","year":"1987","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.vaccine.2022.01.049_b0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Russell","year":"1977","journal-title":"J Gen Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2022.01.049_b0095","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.vaccine.2015.12.006","article-title":"Efficient generation of vesicular stomatitis virus (VSV)-pseudotypes bearing morbilliviral glycoproteins and their use in quantifying virus neutralising antibodies","volume":"34","author":"Logan","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.01.049_b0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jviromet.2014.09.021","article-title":"Lyophilisation of influenza, rabies and Marburg lentiviral pseudotype viruses for the development and distribution of a neutralisation -assay-based diagnostic kit","volume":"210","author":"Mather","year":"2014","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2022.01.049_b0105","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2307\/3001968","article-title":"Individual comparisons by ranking methods","volume":"1","author":"Wilcoxon","year":"1945","journal-title":"Biometrics Bull"},{"issue":"1","key":"10.1016\/j.vaccine.2022.01.049_b0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1214\/aoms\/1177730491","article-title":"On a test of whether one of two random variables is stochastically larger than the other","volume":"18","author":"Mann","year":"1947","journal-title":"Ann Math Stat"},{"issue":"11","key":"10.1016\/j.vaccine.2022.01.049_b0115","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00209-17","article-title":"Antigenic drift defines a new D4 subgenotype of measles virus","volume":"91","author":"Mu\u00f1oz-Al\u00eda","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2022.01.049_b0120","doi-asserted-by":"crossref","unstructured":"Finsterbusch T, Wolbert A, Deitemeier I, Meyer K, Mosquera MM, Mankertz A, et al. Measles viruses of genotype H1 evade recognition by vaccine-induced neutralizing antibodies targeting the linear haemagglutinin noose epitope 2019:2739\u201345. doi: 10.1099\/vir.0.013524-0.","DOI":"10.1099\/vir.0.013524-0"},{"key":"10.1016\/j.vaccine.2022.01.049_b0125","doi-asserted-by":"crossref","unstructured":"Filia A, Amendola A, Faccini M, Del Manso M, Senatore S, Bianchi S, et al. Outbreak of a new measles B3 variant in the Roma\/Sinti population with transmission in the nosocomial setting, Italy, November 2015 to April 2016. Euro Surveill 2016;21. doi: 10.2807\/1560-7917.ES.2016.21.20.30235.","DOI":"10.2807\/1560-7917.ES.2016.21.20.30235"},{"key":"10.1016\/j.vaccine.2022.01.049_b0130","doi-asserted-by":"crossref","unstructured":"World Health Organisation. WHO | Weekly Epidemiological Record, 13 November 2020, vol. 95, 46 (pp. 557\u2013572). Wkly Epidemiol Rec 2020;95:557\u201372. doi: 10.2471\/BLT.19.241620.","DOI":"10.2471\/BLT.19.241620"},{"key":"10.1016\/j.vaccine.2022.01.049_b0135","unstructured":"World Health Organisation. Measles vaccines: WHO position paper - April 2017. Wkly Epidemiol Rec Epidemiol Rec 2017;92:205\u201327."},{"key":"10.1016\/j.vaccine.2022.01.049_b0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2431-11-29","article-title":"Phagocytic ability of neutrophils and monocytes in neonates","volume":"11","author":"Filias","year":"2011","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.vaccine.2022.01.049_b0145","doi-asserted-by":"crossref","first-page":"E44","DOI":"10.25011\/cim.v30i2.979","article-title":"Human newborn polymorphonuclear neutrophils exhibit decreased levels of MyD88 and attenuated p38 phosphorylation in response to lipopolysaccharide","volume":"30","author":"Al-Hertani","year":"2007","journal-title":"Clin Investig Med"},{"issue":"1","key":"10.1016\/j.vaccine.2022.01.049_b0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4049\/jimmunol.176.1.165","article-title":"Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival","volume":"176","author":"Pihlgren","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2022.01.049_b0155","first-page":"106","article-title":"Measles antibody in mothers and infants 0\u20132 years and response to measles vaccine at the age of 9 and 18 months","volume":"90","author":"Techasena","year":"2007","journal-title":"J Med Assoc Thail"},{"key":"10.1016\/j.vaccine.2022.01.049_b0160","doi-asserted-by":"crossref","unstructured":"Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P. Early waning of maternal measles antibodies in era of measles elimination: Longitudinal study. BMJ 2010;340:c1626. doi: 10.1136\/bmj.c1626.","DOI":"10.1136\/bmj.c1626"},{"issue":"14-15","key":"10.1016\/j.vaccine.2022.01.049_b0165","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0264-410X(98)00100-5","article-title":"Determinants of infant responses to vaccines in presence of maternal antibodies","volume":"16","author":"Siegrist","year":"1998","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2022.01.049_b0170","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0022-3476(77)81021-4","article-title":"Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure","volume":"91","author":"Albrecht","year":"1977","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2022.01.049_b0175","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2471\/BLT.10.080010","article-title":"Blood sample volume limits in child health research: review of save limits","volume":"89","author":"Howie","year":"2011","journal-title":"Bull World Heal Organ"},{"issue":"5","key":"10.1016\/j.vaccine.2022.01.049_b0180","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.tree.2007.12.006","article-title":"Maternal transfer of antibodies: raising immuno-ecology issues","volume":"23","author":"Boulinier","year":"2008","journal-title":"Trends Ecol Evol"},{"issue":"6","key":"10.1016\/j.vaccine.2022.01.049_b0185","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00281-017-0653-x","article-title":"Transfer of maternal immunity and programming of the newborn immune system","volume":"39","author":"Jennewein","year":"2017","journal-title":"Semin Immunopathol"},{"issue":"5","key":"10.1016\/j.vaccine.2022.01.049_b0190","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0022-3476(86)81039-3","article-title":"Maternally derived measles immunity in era of vaccine-protected mothers","volume":"108","author":"Lennon","year":"1986","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.vaccine.2022.01.049_b0195","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1017\/S095026880005442X","article-title":"Maternally derived measles immunity in children of naturally infected and vaccinated mothers","volume":"101","author":"Jenks","year":"1988","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2022.01.049_b0200","first-page":"447","article-title":"Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity","volume":"96","author":"Maldonado","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.01.049_b0205","unstructured":"Szenborn L, Tischer A, Pejcz J, Rudkowski Z, W\u00f3jcik M. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers. Med Sci Monit 2003;9:CR541-6."},{"issue":"2","key":"10.1016\/j.vaccine.2022.01.049_b0210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jmv.1890450220","article-title":"Measles antibodies in women and infants in the vaccine era","volume":"45","author":"Kacica","year":"1995","journal-title":"J Med Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2022.01.049_b0215","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/00006454-199511000-00008","article-title":"Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel","volume":"14","author":"Dagan","year":"1995","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22000950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22000950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:09:55Z","timestamp":1759403395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22000950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0264410X22000950"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.01.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the effect of maternally derived antibody on response to MMR vaccine in Thai infants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.01.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}